卫信康(603676)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603676 卫信康

已收盘 03-10 15:00:00

{"stockData":{"symbol":"603676","market":"SH","secType":"STK","nameCN":"卫信康","latestPrice":11.04,"timestamp":1773126001000,"preClose":10.8,"halted":0,"volume":1255400,"delay":0,"changeRate":0.0222,"floatShares":434999999,"shares":434999999,"eps":0.5104,"marketStatus":"已收盘","change":0.24,"latestTime":"03-10 15:00:00","open":10.95,"high":11.04,"low":10.85,"amount":13789200,"amplitude":0.0176,"askPrice":11.04,"askSize":176,"bidPrice":11.03,"bidSize":3,"shortable":0,"etf":0,"ttmEps":0.5104,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773192600000},"marketStatusCode":5,"adr":0,"adjPreClose":10.8,"symbolType":"stock","openAndCloseTimeList":[[1773106200000,1773113400000],[1773118800000,1773126000000]],"highLimit":11.88,"lowLimit":9.72,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":435161500,"isCdr":false,"pbRate":3.15,"roa":"--","peRate":21.630094,"roe":"15.01%","epsLYR":0.57,"committee":-0.671289,"marketValue":4804000000,"turnoverRate":0.0029,"status":0,"floatMarketCap":4804000000},"requestUrl":"/m/hq/s/603676/wiki","defaultTab":"wiki","newsList":[{"id":"2617636246","title":"每周股票复盘：卫信康（603676）子公司获注射用硫酸艾沙康唑注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2617636246","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617636246?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:14","pubTimestamp":1772910853,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，卫信康报收于10.91元，较上周的11.23元下跌2.85%。本周，卫信康3月2日盘中最高价报11.22元。本周关注点来自公司公告汇总：子公司获注射用硫酸艾沙康唑药品注册证书，视同通过一致性评价。公司公告汇总西藏卫信康医药股份有限公司全资子公司内蒙古白医制药股份有限公司近日收到国家药品监督管理局核准签发的注射用硫酸艾沙康唑《药品注册证书》，批准注册并视同通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0239","BK0191"],"gpt_icon":0},{"id":"2617686498","title":"卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2617686498","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617686498?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:37","pubTimestamp":1772789822,"startTime":"0","endTime":"0","summary":"智通财经APP讯，卫信康(603676.SH)发布公告，近日，公司全资子公司内蒙古白医制药股份有限公司(简称“白医制药”)收到国家药品监督管理局核准签发的注射用硫酸艾沙康唑《药品注册证书》。注射用硫酸艾沙康唑适用于治疗成人患者下列感染：侵袭性曲霉病，侵袭性毛霉病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603676","BK0239","BK0191"],"gpt_icon":0},{"id":"2588015850","title":"卫信康(603676.SH)：利多卡因丁卡因乳膏获药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2588015850","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588015850?lang=zh_cn&edition=full","pubTime":"2025-12-03 15:43","pubTimestamp":1764747793,"startTime":"0","endTime":"0","summary":"利多卡因丁卡因乳膏由Zars公司研发，在2006年6月29日获美国FDA批准，商品名为Pliaglis，规格为每g含利多卡因70mg与丁卡因70mg。国家药监局公布的第 31 批参比制剂目录中明确了利多卡因丁卡因乳膏参比制剂为美国橙皮书和欧盟上市的未进口原研药品，持证商分别是Taro Pharms 和 Difa Cooper SPA/Galderma Laboratorium GmbH。截至目前，该产品国内暂无上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"卫信康(603676.SH)：利多卡因丁卡因乳膏获药物临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603676","BK0239","BK0191"],"gpt_icon":0},{"id":"2585810680","title":"每周股票复盘：卫信康（603676）每股派现0.147元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585810680","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585810680?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:28","pubTimestamp":1763843292,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，卫信康报收于10.96元，较上周的11.73元下跌6.56%。本周，卫信康11月17日盘中最高价报11.74元。卫信康当前最新总市值47.69亿元，在化学制药板块市值排名102/151，在两市A股市值排名3344/5167。广东信达律师事务所出具法律意见书，确认本次差异化权益分派符合相关法律法规及公司章程规定，未损害上市公司和股东利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603676","BK0239"],"gpt_icon":0},{"id":"2584373956","title":"卫信康（603676）披露2025年前三季度权益分派实施公告，11月18日股价下跌0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584373956","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584373956?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:44","pubTimestamp":1763477056,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，卫信康报收于11.47元，较前一交易日下跌0.61%，最新总市值为49.91亿元。该股当日开盘11.49元，最高11.58元，最低11.41元，成交额达1714.44万元，换手率为0.34%。近日，西藏卫信康医药股份有限公司发布2025年前三季度权益分派实施公告。股权登记日为2025年11月25日，除权除息日与现金红利发放日均为2025年11月26日。本次合计拟派发现金红利63,553,215.60元（含税），占2025年前三季度归母净利润的29.00%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800040290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","603676"],"gpt_icon":0},{"id":"2582786491","title":"每周股票复盘：卫信康（603676）拟每10股派1.47元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582786491","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582786491?lang=zh_cn&edition=full","pubTime":"2025-11-09 05:06","pubTimestamp":1762635978,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，卫信康报收于11.26元，较上周的11.15元上涨0.99%。本周，卫信康11月3日盘中最高价报11.35元。本周关注点来自机构调研要点：公司拟每10股派发现金股利1.47元（含税）。2025年第三季度，公司一次性补缴企业所得税及滞纳金合计2,185.81万元，本事项不涉及行政处罚。公司补缴上述税款及滞纳金全部计入2025年当期损益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","603676"],"gpt_icon":0},{"id":"2581011659","title":"股市必读：卫信康（603676）11月6日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2581011659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581011659?lang=zh_cn&edition=full","pubTime":"2025-11-07 03:04","pubTimestamp":1762455853,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，卫信康报收于11.22元，上涨0.36%，换手率0.39%，成交量1.7万手，成交额1897.81万元。来自机构调研要点：公司多种微量元素注射液在多个省份集采中选，并完成接续采购。2025年第三季度，公司一次性补缴企业所得税及滞纳金合计2,185.81万元，该事项不涉及行政处罚，相关金额计入当期损益，不追溯调整前期财务数据。2025年9月至10月期间，该产品相继在京津冀“3+N”联盟接续采购、陕西十四省集采、广东联盟接续采购中中选。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700002526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0191","BK0239"],"gpt_icon":0},{"id":"2580032844","title":"每周股票复盘：卫信康（603676）股东户数增14.14%，Q3净利降54.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580032844","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580032844?lang=zh_cn&edition=full","pubTime":"2025-11-02 09:56","pubTimestamp":1762048572,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，卫信康报收于11.15元，较上周的11.89元下跌6.22%。本周，卫信康10月28日盘中最高价报11.95元。卫信康当前最新总市值48.52亿元，在化学制药板块市值排名110/151，在两市A股市值排名3412/5163。股本股东变化截至2025年9月30日，公司股东户数为1.65万户，较6月30日增加2047户，增幅14.14%。其中第三季度主营收入2.76亿元，同比下降23.5%；单季度归母净利润3638.86万元，同比下降54.4%；扣非净利润3258.03万元，同比下降59.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603676","BK0239"],"gpt_icon":0},{"id":"2579095521","title":"股市必读：卫信康（603676）10月30日收盘跌7.13%，主力净流出1080.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579095521","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579095521?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:21","pubTimestamp":1761862903,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘，卫信康报收于10.94元，下跌7.13%，换手率1.88%，成交量8.19万手，成交额9065.98万元。当日关注点来自交易信息汇总：卫信康股价连续5日下跌，10月30日收盘报10.94元，跌幅7.13%。来自公司公告汇总：卫信康拟每10股派发现金股利1.47元（含税），合计派现63,553,215.60元（含税），占前三季度净利润的29.00%。前10个交易日主力资金累计净流出1884.1万元，同期股价累计下跌7.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100007935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","603676"],"gpt_icon":0},{"id":"2579109502","title":"卫信康（603676）2025年三季报简析：净利润同比下降9.9%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109502","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579109502?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:20","pubTimestamp":1761862807,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期卫信康发布2025年三季报。截至本报告期末，公司营业总收入8.62亿元，同比下降13.27%，归母净利润2.19亿元，同比下降9.9%。按单季度数据看，第三季度营业总收入2.76亿元，同比下降23.5%，第三季度归母净利润3638.86万元，同比下降54.4%。本报告期卫信康盈利能力上升，毛利率同比增幅13.07%，净利率同比增幅3.88%。持有卫信康最多的基金为湘财医药健康混合A，目前规模为0.17亿元，最新净值1.6584，较上一交易日下跌0.9%，近一年上涨5.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100007875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676"],"gpt_icon":0},{"id":"2579711179","title":"图解卫信康三季报：第三季度单季净利润同比下降54.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579711179","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579711179?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:53","pubTimestamp":1761735225,"startTime":"0","endTime":"0","summary":"证券之星消息，卫信康2025年三季报显示，前三季度公司主营收入8.62亿元，同比下降13.27%；归母净利润2.19亿元，同比下降9.9%；扣非净利润1.69亿元，同比下降14.01%；其中2025年第三季度，公司单季度主营收入2.76亿元，同比下降23.5%；单季度归母净利润3638.86万元，同比下降54.4%；单季度扣非净利润3258.03万元，同比下降59.74%；负债率20.06%，投资收益1161.36万元，财务费用-111.28万元，毛利率61.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676"],"gpt_icon":0},{"id":"2579920125","title":"卫信康(603676)9月30日股东户数1.65万户，较上期增加14.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579920125","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579920125?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:19","pubTimestamp":1761729569,"startTime":"0","endTime":"0","summary":"证券之星消息，近日卫信康披露，截至2025年9月30日公司股东户数为1.65万户，较6月30日增加2047.0户，增幅为14.14%。在化学制药行业个股中，卫信康股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.38万户。从股价来看，2025年6月30日至2025年9月30日，卫信康区间涨幅为15.3%，在此期间股东户数增加2047.0户，增幅为14.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900035480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","603676"],"gpt_icon":0},{"id":"2567139100","title":"每周股票复盘：卫信康（603676）2025年中期分红待定，上半年净利增11.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567139100","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567139100?lang=zh_cn&edition=full","pubTime":"2025-09-14 06:14","pubTimestamp":1757801652,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，卫信康报收于12.44元，较上周的12.3元上涨1.14%。本周，卫信康9月9日盘中最高价报13.29元。来自机构调研要点：2025年上半年公司实现净利润1.83亿元，同比增长11.82%。来自公司公告汇总：多项公司治理制度于2025年9月完成修订并生效。答：2025年上半年，公司实现营业收入5.86亿元，同比下降7.43%；实现归母净利润1.83亿元，同比增长11.82%；扣非净利润1.37亿元，同比增长17.86%。董事会成员将由7人增至8人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603676","BK0191"],"gpt_icon":0},{"id":"2518901552","title":"卫信康03月10日获主力加仓173万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518901552","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518901552?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:21","pubTimestamp":1741591263,"startTime":"0","endTime":"0","summary":"03月10日, 卫信康股价涨2.72%，报收9.83元，成交金额3576万元，换手率0.84%，振幅3.13%，量比1.47。卫信康今日主力资金净流入173万元，上一交易日主力净流入174万元。|03月10日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|华丰股份|6.05%|#|中科云网|4.14%|#|黄河旋风|4.03%|#|泰尔股份|3.98%|#|塞力医疗|3.96%|#|东方锆业|3.83%|#|海立股份|3.57%|#|创业慧康|3.57%|#|威派格|3.49%|#|博济医药|3.48%|卫信康所在的化学制药行业，今日主力净流出6186万元，行业排名55/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310161951abf27fc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310161951abf27fc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603676","BK0191"],"gpt_icon":0},{"id":"2516644169","title":"卫信康03月04日遭主力抛售34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516644169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516644169?lang=zh_cn&edition=full","pubTime":"2025-03-04 15:21","pubTimestamp":1741072862,"startTime":"0","endTime":"0","summary":"03月04日, 卫信康股价跌0.73%，报收9.53元，成交金额2369万元，换手率0.57%，振幅1.46%，量比0.93。卫信康今日主力资金净流出34万元，上一交易日主力净流出219万元。|03月04日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|N常友科技|31.45%|#|N汇通|19.85%|#|赛为智能|9.60%|#|北方长龙|7.84%|#|信邦智能|6.61%|#|好上好|6.38%|#|南方精工|5.45%|#|创业慧康|5.14%|#|城地香江|4.48%|#|立航科技|4.32%|卫信康所在的化学制药行业，今日主力净流出6.19亿元，行业排名7/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304162121a25e863c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304162121a25e863c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603676","BK0239","BK0191"],"gpt_icon":0},{"id":"2514376312","title":"卫信康：注射用多种维生素（12）在河北、江苏集采中中选","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376312","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514376312?lang=zh_cn&edition=full","pubTime":"2025-02-28 16:06","pubTimestamp":1740730015,"startTime":"0","endTime":"0","summary":"金融界2月28日消息， 卫信康披露投资者关系活动记录表显示，公司注射用多种维生素（12）在河南十九省联盟集中带量采购、浙江第四批药品集中带量采购中中选，截止2024年末，共有20个省（区、兵团）正式执行中选结果。2025年1月，注射用多种维生素（12）在河北牵头的京津冀赣化学药品集中带量采购、江苏省第五轮药品集中带量采购中中选。公司多种微量元素注射液在京津冀“3+N”联盟集中带量采购中中选，截止2024年末，共有11个省（区、兵团）正式执行中选结果。2025年1月，江苏省第五轮药品集采拟中选结果公布，多种微量元素注射液、多种微量元素注射液(I) 拟中选。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281609279633aac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502281609279633aac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","BK0239","603676"],"gpt_icon":0},{"id":"2514205127","title":"卫信康：产品“复方氨基酸注射液”取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2514205127","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514205127?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:52","pubTimestamp":1740469964,"startTime":"0","endTime":"0","summary":"每经AI快讯，卫信康 2月25日晚间发布公告称，近日，西藏卫信康医药股份有限公司全资子公司内蒙古白医制药股份有限公司收到国家药品监督管理局核准签发的复方氨基酸注射液《药品注册证书》。产品名称为“复方氨基酸注射液”。2023年1至12月份，卫信康的营业收入构成为：医药制造业占比99.97%。卫信康的总经理、董事长均是张勇，男，52岁，学历背景为硕士。截至发稿，卫信康市值为41亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225155323962f86af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225155323962f86af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603676","BK0239","BK0191"],"gpt_icon":0},{"id":"2514505689","title":"卫信康(603676.SH)获得复方氨基酸注射液(18AA-Ⅶ)药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2514505689","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514505689?lang=zh_cn&edition=full","pubTime":"2025-02-25 15:32","pubTimestamp":1740468765,"startTime":"0","endTime":"0","summary":"智通财经APP讯，卫信康(603676.SH)公告，近日，公司全资子公司内蒙古白医制药股份有限公司(简称“白医制药”)收到国家药品监督管理局(简称“国家药监局”)核准签发的复方氨基酸注射液(18AA-Ⅶ)《药品注册证书》。复方氨基酸注射液(18AA-Ⅶ)为成人氨基酸补充剂，用于低蛋白血症、低营养状态和手术前后的氨基酸补充。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603676","BK0191"],"gpt_icon":0},{"id":"2513126747","title":"卫信康02月24日遭主力抛售73万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513126747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513126747?lang=zh_cn&edition=full","pubTime":"2025-02-24 18:56","pubTimestamp":1740394586,"startTime":"0","endTime":"0","summary":"02月24日, 卫信康股价跌0.31%，报收9.53元，成交金额2345万元，换手率0.57%，振幅2.20%，量比0.92。卫信康今日主力资金净流出73万元，上一交易日主力净流出279万元。|02月24日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|天舟文化|7.59%|#|元道通信|4.90%|#|新研股份|4.74%|#|中设股份|4.53%|#|众辰科技|4.42%|#|福日电子|4.05%|#|南兴股份|3.97%|#|华平股份|3.70%|#|粤宏远Ａ|3.53%|#|瑞贝卡|3.43%|卫信康所在的化学制药行业，今日主力净流出5.09亿元，行业排名32/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224194835abdadf7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224194835abdadf7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603676","BK0191"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773158141623,"stockEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0383},{"period":"3month","weight":-0.0217},{"period":"6month","weight":-0.1261},{"period":"1year","weight":0.1615},{"period":"ytd","weight":0.0266}],"compareEarnings":[{"period":"1week","weight":-0.0206},{"period":"1month","weight":0.0076},{"period":"3month","weight":0.0479},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.2147},{"period":"ytd","weight":0.0322}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏卫信康医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"16525人(较上一季度增加14.14%)","perCapita":"26333股","listingDate":"2017-07-21","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区B区园区南路5号工业中心4号楼3层","registeredCapital":"43516万元","survey":"　　西藏卫信康医药股份有限公司的主营业务是化学药品制剂及其原料药的研发、生产、销售。公司的主要产品是注射用多种维生素（12）、多种微量元素注射液、小儿多种维生素注射液（13）。","listedPrice":5.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"卫信康(603676)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供卫信康(603676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"卫信康,603676,卫信康股票,卫信康股票老虎,卫信康股票老虎国际,卫信康行情,卫信康股票行情,卫信康股价,卫信康股市,卫信康股票价格,卫信康股票交易,卫信康股票购买,卫信康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"卫信康(603676)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供卫信康(603676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}